These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13118247)

  • 1. The inhibition of respiration of certain dermatophytes by beta propiolactone.
    GALE GR
    J Invest Dermatol; 1954 Jan; 22(1):1-3. PubMed ID: 13118247
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of beta-propiolactone on metabolism of pseudomonas aeruginosa and growth of certain fungi.
    BERNHEIM F; GALE GR
    Proc Soc Exp Biol Med; 1952 May; 80(1):162-4. PubMed ID: 14930106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biology of pathogenic dermatophytes; the antagonism of fungi among each other].
    VON MALLINCKRODT-HAUPT AS
    Z Haut Geschlechtskr; 1953 Aug; 15(3):74-8. PubMed ID: 13103270
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of beta-propiolactone on bacterial spores.
    CURRAN HR; EVANS FR
    J Infect Dis; 1956; 99(3):212-8. PubMed ID: 13376916
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of beta-propiolactone on the metabolism of Candida albicans.
    GALE GR
    J Infect Dis; 1955; 96(3):250-8. PubMed ID: 14392370
    [No Abstract]   [Full Text] [Related]  

  • 6. The activity of human regains exposed to the disinfectant, beta-propiolactone.
    FLICK JA; FEINBERG RJ
    J Allergy; 1955 May; 26(3):262-7. PubMed ID: 14366906
    [No Abstract]   [Full Text] [Related]  

  • 7. The carcinogenicity of beta-propiolactone for mouseskin.
    GLENDENNING OM; ROE FJ
    Br J Cancer; 1956 Jun; 10(2):357-62. PubMed ID: 13364127
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.
    Sekhon AS; Funk A
    J Antimicrob Chemother; 1977 Jan; 3(1):95-100. PubMed ID: 845106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inactivation and antigenicity of poliomyelitis virus type 2 (MEF-1 strain) treated with beta-propiolactone].
    D'ALESSANDRO G; ODDO FG; INSERILLO G
    Riv Ist Sieroter Ital; 1956; 31(1):65-8. PubMed ID: 13337026
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenicity of beta-propiolactone-inactivated virus vaccines.
    LOGRIPPO GA; HARTMAN FW
    J Immunol; 1955 Aug; 75(2):123-8. PubMed ID: 13242811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antigenic and vaccinating power of Newcastle virus inactivated by beta-propiolactone].
    LEPINE P; ATANASIU P
    Ann Inst Pasteur (Paris); 1956 Jul; 91(1):100-2. PubMed ID: 13340335
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus.
    SMOLENS J; STOKES J
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimycotic effects of some antibiotics on the growth of some dermatophytes and other keratin degrading fungi.
    Singh CJ; Singh BG
    Hindustan Antibiot Bull; 1997; 39(1-4):61-3. PubMed ID: 10386017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological response in chickens to beta-propiolactone treated Newcastle disease virus.
    MACK WN; CHOTISEN A
    Proc Soc Exp Biol Med; 1956 Feb; 91(2):288-90. PubMed ID: 13297779
    [No Abstract]   [Full Text] [Related]  

  • 16. Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse.
    ROE FJ; SALAMAN MH
    Br J Cancer; 1955 Mar; 9(1):177-203. PubMed ID: 14378502
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-propiolactone and beta-nitropropionic acid on rat brain monoamine oxidase.
    Mohammed YS; Mahfouz MM; Osman MY
    Biochem Pharmacol; 1977 Jan; 26(1):62-3. PubMed ID: 831726
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of essential oil from fruits of Indian Cuminum cyminum.
    Romagnoli C; Andreotti E; Maietti S; Mahendra R; Mares D
    Pharm Biol; 2010 Jul; 48(7):834-8. PubMed ID: 20645785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.